XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity          
Beginning balance (in shares)   62,816,039      
Beginning balance at Dec. 31, 2020 $ 73,376 $ 63 $ 785,673 $ 0 $ (712,360)
Increase (Decrease) in Stockholders' Equity          
Share-based compensation 2,584   2,584    
Exercise of stock options 3,530 $ 1 3,529    
Exercise of stock options (in shares)   710,132      
Employee stock purchase plan purchases 330   330    
Employee stock purchase plan purchases (in shares)   259,837      
RSU stock issuance (in shares)   168,752      
Issuance of common stock related to asset acquisition 43,445 $ 9 43,436    
Issuance of common stock related to asset acquisition (in shares)   8,723,769      
Issuance of common stock, net of issuance costs 107,842 $ 13 107,829    
Issuance of common stock, net of issuance costs (in shares)   13,529,750      
Comprehensive loss:          
Unrealized loss on investments, net (43)     (43)  
Net loss (97,415)       (97,415)
Comprehensive loss (97,458)        
Ending balance at Mar. 31, 2021 133,649 $ 86 943,381 (43) (809,775)
Ending balance (in shares) at Mar. 31, 2021   86,208,279      
Increase (Decrease) in Stockholders' Equity          
Beginning balance (in shares)   86,208,279      
Beginning balance (in shares)   86,884,266      
Beginning balance at Dec. 31, 2021 68,252 $ 87 953,782 (21) (885,596)
Increase (Decrease) in Stockholders' Equity          
Share-based compensation 3,708   3,708    
Exercise of stock options 102   102    
Exercise of stock options (in shares)   34,406      
Employee stock purchase plan purchases 555   555    
Employee stock purchase plan purchases (in shares)   383,981      
RSU stock issuance (in shares)   133,527      
Comprehensive loss:          
Unrealized loss on investments, net (52)     (52)  
Net loss (24,767)       (24,767)
Comprehensive loss (24,819)        
Ending balance at Mar. 31, 2022 $ 47,798 $ 87 $ 958,147 $ (73) $ (910,363)
Ending balance (in shares) at Mar. 31, 2022   87,436,180      
Increase (Decrease) in Stockholders' Equity          
Beginning balance (in shares)   87,436,180